CD8A and neoplasm: To determine if the observed changes in intratumoral CD8+ T cell populations following combination therapy were necessary for a reduction in tumor size, we treated 344SQ tumors with ellagic acid and anti-PD-1, along with control or a CD8-depleting antibody.